Genetic Technologies Limited
GENE

$3.71 M
Marketcap
$0.77
Share price
Country
$0.00
Change (1 day)
$3.59
Year High
$0.67
Year Low

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

marketcap

Revenue of Genetic Technologies Limited (GENE)

Revenue in 2024 (TTM): $7.66 M

According to Genetic Technologies Limited's latest financial reports the company's current revenue (TTM) is $7.66 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Genetic Technologies Limited

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2024 $7.66 M $3.9 M $-11,430,709 $-12,017,219 $-12,017,219
2023 $10.35 M $6.01 M $-11,203,154 $-11,909,252 $-11,750,923
2022 $6.79 M $6.47 M $-7,200,621 $-7,163,123 $-7,130,998
2021 $120.55 K $-240,473 $-7,063,570 $-7,077,619 $-7,077,619
2020 $837.87 K $736.43 K $-5,873,355 $-6,294,775 $-6,294,775
2019 $25.44 K $-250,823 $-6,861,600 $-6,425,604 $-6,425,604
2018 $189.25 K $-110,834 $-5,459,470 $-5,463,872 $-5,463,872
2017 $518.51 K $26.09 K $-7,799,638 $-8,403,826 $-8,403,826
2016 $824.59 K $81.53 K $-8,104,464 $-8,458,965 $-8,458,965
2015 $2.01 M $685.26 K $-8,424,458 $-8,810,170 $-8,810,170
2014 $4.56 M $1.65 M $-9,047,538 $-10,134,469 $-10,125,197
2013 $3.38 M $1.43 M $-8,927,952 $-9,349,483 $-9,349,483
2012 $11.33 M $9.38 M $-4,735,314 $-5,296,828 $-5,287,523
2011 $18.28 M $16.24 M $1.58 M $901.34 K $910 K
2010 $9.76 M $7.04 M $-5,548,456 $-9,355,209 $-9,343,766
2009 $6.67 M $3.94 M $-4,250,330 $-9,737,088 $-9,715,717
2008 $15.74 M $14.84 M $1.47 M $-5,463,345 $-5,457,784
2007 $13.76 M $7.19 M $158.63 K $-1,435,424 $-1,665,678
2006 $9.9 M $1.83 M $-4,275,147 $-5,315,974 $-5,417,868
2005 $9.47 M $4.85 M $-6,217,742 $-7,229,657 $-7,531,763
2004 $3.78 M $594.57 K $-7,028,947 $-6,816,267 $-6,889,411
2003 $9.26 M $9.26 M $-841,519 $-4,325,345 $-4,325,345
2002 $13.11 M $13.11 M $-2,685,588 $-8,888,430 $-8,824,594
2001 $5.63 M $5.63 M $35.51 K $-3,443,603 $-3,390,403
2000 $4.02 M $4.02 M $-2,515,193 $-2,809,410 $-2,439,598